Mouse IFN-γ T cell ELISPOT antibody pair - 20-plate

SKU
CT655-20
Validated ELISPOT antibody pair; reagents available separately (1920 determinations).
Format
20-plate
Price
€ 1,160
Reactivity
Mouse
Category
T cell ELISPOT
Analyte
IFN-γ
Description
Our ELISPOT antibody pairs are validated for high assay performance using the same reagents and materials included in U-CyTech ELISPOT kits. These antibody pairs are optimized for reliable and reproducible ELISPOT assays.
The antibody pairs are available in convenient 10-plate and 20-plate format, providing 960 or 1920 determinations, respectively.
Compatible reagents for ELISPOT assays can be purchased separately, allowing customization of your ELISPOT workflow.
Description
IFN-γ is a potent immune regulating cytokine that plays a central role in activating the body’s defense against infections and malignant cells. By enhancing antigen presentation and boosting the activity of T cells and natural killer (NK) cells, IFN-γ drives strong antiviral and anti tumor responses. It is primarily produced by activated T helper 1 (Th1) cells, cytotoxic T cells, γδ T cells, NK cells, and natural killer T (NKT) cells, making it a key indicator of cellular immune activation in research and diagnostic applications.
Alternative names
IFN-γ, IFN-gamma, IFN-g, IFNg, interferon γ, interferon-γ, interferon-gamma, interferon gamma, INF-g, INF-gamma, immune interferon, Type II interferon
Image

References

Authors, et al. Title Journal Year Volume Pages
Xueliang Wang Intranasal immunization with live attenuated influenza vaccine plus chitosan as an adjuvant protects mice against homologous and heterologous virus challenge Arch Virol 2012 157 1451-61
Hao Jin Nicotine stimulated bone marrow-derived dendritic cells could augment HBV specific CTL priming by activating PI3K-Akt pathway Immunol Lett 2012 146 40-9
Seyed Jalali Induction of tumor-specific immunity by multi-epitope rat HER2/neu-derived peptides encapsulated in LPD Nanoparticles Nanomedicine 2012 8 692-701
Émmanuelle Énée ZnT8 is a major CD8+ T cell-recognized autoantigen in pediatric type 1 diabetes Diabetes 2012 61 1779-84
Zhi-peng Hu Characterization of the immune responses elicited by baculovirus-based vector vaccines against influenza virus hemagglutinin Acta Pharmacol Sin 2012 33 783-90
Chang Zhou Immunization with high epitope density of M2e derived from 2009 pandemic H1N1 elicits protective immunity in mice Vaccine 2012 30 3463-9
Chasity Andrews Encapsulating immunostimulatory CpG oligonucleotides in listeriolysin O-liposomes promotes a Th1-type response and CTL activity Mol Pharm 2012 9 1118-25
Y Luo Subunit vaccine candidate AMM down-regulated the regulatory T cells and enhanced the protective immunity of BCG on a suitable schedule Scand J Immunol 2012 75 293-300
Chia-Hung Chen Liposome-based polymer complex as a novel adjuvant: enhancement of specific antibody production and isotype switch Int J Nanomedicine 2012 7 607-21
Chia-Hung Chen Liposome-based polymer complex as a novel adjuvant: enhancement of specific antibody production and isotype switch Int J Nanomedicine 2012 7 607-21